Тёмный

Alvaro Pascual-Leone: Transcranial Magnetic Stimulation for Brain Disorders in the Digital Age 

BRAIN PONDERINGS podcast with Mark Mattson
Подписаться 1,7 тыс.
Просмотров 314
50% 1

Transcranial magnetic stimulation (TMS) is a non-invasive technology that enables stimulation (or inhibition) of specified neuronal networks in the brain. In this episode Alvaro Pascual-Leone, a Professor in Neurology at Harvard Medical School, talks about the principle and practice of TMS and its use for the treatment of a range of brain disorders including depression, stroke, and cognitive impairment, chronic pain, and traumatic brain injuries. The technology has advanced to a point where portable in-home devices can be used for treatments under the supervision of medical experts. TMS is also being used to understand how neural networks respond to injury and disease. TMS promises to be a valuable addition to therapies for mental and neurodegenerative disorders. In addition to TMS Dr. Pascual-Leone is working to develop and apply artificial intelligence and digital technologies and intelligent therapy assistant approaches to the broader health care system.
In addition to being a Professor at Harvard, Dr. Pascual-Leone is Medical Director, Deanna and Sidney Wolk Center for Memory Health; Senior Scientist, Hinda and Arthur Marcus Institute for Aging ResearchvHebrew SeniorLife; Co Founder and Chief Medical Office Linus Health; Co Founder TI Solutions
LINKS:
Review articles on TMS:
www.ncbi.nlm.nih.gov/pmc/arti...
www.ncbi.nlm.nih.gov/pmc/arti...
www.ncbi.nlm.nih.gov/pmc/arti...
Article on digital technology intelligent therapy assistants:
www.ncbi.nlm.nih.gov/pmc/arti...

Опубликовано:

 

5 авг 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 2   
@losindigenas
@losindigenas 5 дней назад
Thanks For share with the World, this amazing lectures and discuss. I love Neuroscience, my dream in the future is will work in this field. Best regards from Nicaragua. A Little country in Central America.
@EJJonCampbell
@EJJonCampbell Месяц назад
Are you aware of any trials in the use of TMS with pediatric patients (16 years old) with brain damage post ADEM? Damage includes: cognitive, right side weakness (functional & sensory) & right-side visual cut (occipital lobe damage to left side). 17:31 / 51:26 Alvaro Pascual-Leone
Далее
Это реально работает?!
00:33
Просмотров 2,5 млн
Reduce dementia risk
50:27
Просмотров 543 тыс.
Moderna v Pfizer, deaths
24:43
Просмотров 664 тыс.